InsidersTradesSigma
Track the 华特达因 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 华特达因 has recorded 4 public disclosures. Market capitalisation: €5.9bn. The latest transaction was filed on 24 April 2026 (Purchase). Among the most active insiders: 范智胜. The full history is openly available.
4
Insider Decl.
n/a
Thresholds
€250,502
4 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 107 of 29,063 companies
90.5
score / 100
Value90
Quality91
FCF yld20%
Earn yld8.8%
EV/EBITDA4.8x
ROE20%
Gross mgn85%
Net mgn24%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
关于 华特达因
华特达因是一家在健康和制药领域运营的公司，在 XSHE 市场上市。该公司专注于药品和保健产品的开发和分销。